CN111000773A - Preparation method of pholiota nameko mucilage and skin care product and beauty food prepared from pholiota nameko mucilage - Google Patents
Preparation method of pholiota nameko mucilage and skin care product and beauty food prepared from pholiota nameko mucilage Download PDFInfo
- Publication number
- CN111000773A CN111000773A CN201911419464.5A CN201911419464A CN111000773A CN 111000773 A CN111000773 A CN 111000773A CN 201911419464 A CN201911419464 A CN 201911419464A CN 111000773 A CN111000773 A CN 111000773A
- Authority
- CN
- China
- Prior art keywords
- parts
- extract
- mucilage
- pholiota nameko
- skin care
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000014528 Pholiota nameko Nutrition 0.000 title claims abstract description 117
- 244000168667 Pholiota nameko Species 0.000 title claims abstract description 117
- 229920000715 Mucilage Polymers 0.000 title claims abstract description 82
- 239000000853 adhesive Substances 0.000 title claims abstract description 82
- 230000003796 beauty Effects 0.000 title claims abstract description 19
- 235000013305 food Nutrition 0.000 title claims abstract description 18
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 239000007788 liquid Substances 0.000 claims abstract description 23
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims abstract description 14
- 239000006071 cream Substances 0.000 claims abstract description 8
- 230000001815 facial effect Effects 0.000 claims abstract description 5
- 238000004140 cleaning Methods 0.000 claims abstract description 4
- 238000000034 method Methods 0.000 claims abstract description 4
- 239000000047 product Substances 0.000 claims description 47
- 235000010469 Glycine max Nutrition 0.000 claims description 28
- 244000068988 Glycine max Species 0.000 claims description 28
- 150000001875 compounds Chemical class 0.000 claims description 26
- 102000015636 Oligopeptides Human genes 0.000 claims description 25
- 108010038807 Oligopeptides Proteins 0.000 claims description 25
- 229920001282 polysaccharide Polymers 0.000 claims description 23
- 239000005017 polysaccharide Substances 0.000 claims description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 23
- 150000004676 glycans Chemical class 0.000 claims description 22
- 241001530056 Athelia rolfsii Species 0.000 claims description 21
- 150000001413 amino acids Chemical class 0.000 claims description 20
- 239000003906 humectant Substances 0.000 claims description 20
- 241000196324 Embryophyta Species 0.000 claims description 19
- 241000167854 Bourreria succulenta Species 0.000 claims description 16
- 235000019693 cherries Nutrition 0.000 claims description 16
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 16
- 229920001908 Hydrogenated starch hydrolysate Polymers 0.000 claims description 15
- 241001506047 Tremella Species 0.000 claims description 15
- 235000003095 Vaccinium corymbosum Nutrition 0.000 claims description 15
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims description 15
- 235000021014 blueberries Nutrition 0.000 claims description 15
- 229920001184 polypeptide Polymers 0.000 claims description 15
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 15
- 235000003145 Hippophae rhamnoides Nutrition 0.000 claims description 14
- 230000003266 anti-allergic effect Effects 0.000 claims description 14
- 210000003097 mucus Anatomy 0.000 claims description 14
- 150000005846 sugar alcohols Polymers 0.000 claims description 14
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims description 13
- 240000000851 Vaccinium corymbosum Species 0.000 claims description 13
- 239000012153 distilled water Substances 0.000 claims description 13
- 239000000243 solution Substances 0.000 claims description 12
- 229940109529 pomegranate extract Drugs 0.000 claims description 11
- 108010009736 Protein Hydrolysates Proteins 0.000 claims description 10
- 241000167550 Centella Species 0.000 claims description 9
- 241000220317 Rosa Species 0.000 claims description 9
- 229920006037 cross link polymer Polymers 0.000 claims description 9
- 239000003995 emulsifying agent Substances 0.000 claims description 9
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 8
- 239000011550 stock solution Substances 0.000 claims description 8
- 239000006166 lysate Substances 0.000 claims description 7
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 6
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 6
- 150000002148 esters Chemical class 0.000 claims description 6
- DBLXOVFQHHSKRC-UHFFFAOYSA-N ethanesulfonic acid;2-piperazin-1-ylethanol Chemical compound CCS(O)(=O)=O.OCCN1CCNCC1 DBLXOVFQHHSKRC-UHFFFAOYSA-N 0.000 claims description 6
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 6
- 239000008158 vegetable oil Substances 0.000 claims description 6
- 235000003889 Paeonia suffruticosa Nutrition 0.000 claims description 5
- 240000005001 Paeonia suffruticosa Species 0.000 claims description 5
- 235000018735 Sambucus canadensis Nutrition 0.000 claims description 5
- 235000007123 blue elder Nutrition 0.000 claims description 5
- 229940059958 centella asiatica extract Drugs 0.000 claims description 5
- 235000007124 elderberry Nutrition 0.000 claims description 5
- 235000008995 european elder Nutrition 0.000 claims description 5
- 235000012907 honey Nutrition 0.000 claims description 5
- 239000008213 purified water Substances 0.000 claims description 5
- 229940119485 safflower extract Drugs 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 4
- 239000002131 composite material Substances 0.000 claims description 3
- 229910052710 silicon Inorganic materials 0.000 claims description 3
- 239000010703 silicon Substances 0.000 claims description 3
- 229940059453 millet extract Drugs 0.000 claims description 2
- 240000000950 Hippophae rhamnoides Species 0.000 claims 2
- 239000003973 paint Substances 0.000 claims 2
- 244000151637 Sambucus canadensis Species 0.000 claims 1
- 239000002994 raw material Substances 0.000 abstract description 17
- 239000002537 cosmetic Substances 0.000 abstract description 11
- 239000003755 preservative agent Substances 0.000 abstract description 6
- 238000001914 filtration Methods 0.000 abstract description 2
- 238000012545 processing Methods 0.000 abstract description 2
- 238000003860 storage Methods 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 53
- 230000000694 effects Effects 0.000 description 31
- 241000229143 Hippophae Species 0.000 description 16
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 14
- 239000002562 thickening agent Substances 0.000 description 14
- 230000032683 aging Effects 0.000 description 11
- 206010020751 Hypersensitivity Diseases 0.000 description 9
- 230000003647 oxidation Effects 0.000 description 9
- 238000007254 oxidation reaction Methods 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 208000026935 allergic disease Diseases 0.000 description 8
- 230000007815 allergy Effects 0.000 description 8
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 8
- 230000003020 moisturizing effect Effects 0.000 description 8
- 230000001737 promoting effect Effects 0.000 description 8
- 230000002708 enhancing effect Effects 0.000 description 7
- 230000036039 immunity Effects 0.000 description 7
- -1 nucleic acid polysaccharide amino acid Chemical class 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 208000002874 Acne Vulgaris Diseases 0.000 description 6
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 6
- 229930003268 Vitamin C Natural products 0.000 description 6
- 206010000496 acne Diseases 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 108020004707 nucleic acids Proteins 0.000 description 6
- 102000039446 nucleic acids Human genes 0.000 description 6
- 235000019154 vitamin C Nutrition 0.000 description 6
- 239000011718 vitamin C Substances 0.000 description 6
- 230000002087 whitening effect Effects 0.000 description 6
- 206010061218 Inflammation Diseases 0.000 description 5
- 239000003963 antioxidant agent Substances 0.000 description 5
- 235000006708 antioxidants Nutrition 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 239000003974 emollient agent Substances 0.000 description 5
- 238000000855 fermentation Methods 0.000 description 5
- 230000004151 fermentation Effects 0.000 description 5
- 230000004054 inflammatory process Effects 0.000 description 5
- 150000007523 nucleic acids Chemical class 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 239000000049 pigment Substances 0.000 description 5
- 102000008186 Collagen Human genes 0.000 description 4
- 108010035532 Collagen Proteins 0.000 description 4
- 235000003935 Hippophae Nutrition 0.000 description 4
- 241000208829 Sambucus Species 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 230000036772 blood pressure Effects 0.000 description 4
- 229920001436 collagen Polymers 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 239000000314 lubricant Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 229920002545 silicone oil Polymers 0.000 description 4
- 210000004927 skin cell Anatomy 0.000 description 4
- 230000037303 wrinkles Effects 0.000 description 4
- 206010002198 Anaphylactic reaction Diseases 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- MVORZMQFXBLMHM-QWRGUYRKSA-N Gly-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1 MVORZMQFXBLMHM-QWRGUYRKSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 229920002385 Sodium hyaluronate Polymers 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- 230000000172 allergic effect Effects 0.000 description 3
- 208000003455 anaphylaxis Diseases 0.000 description 3
- 235000010208 anthocyanin Nutrition 0.000 description 3
- 229930002877 anthocyanin Natural products 0.000 description 3
- 239000004410 anthocyanin Substances 0.000 description 3
- 150000004636 anthocyanins Chemical class 0.000 description 3
- 230000002421 anti-septic effect Effects 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 230000004071 biological effect Effects 0.000 description 3
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 239000007957 coemulsifier Substances 0.000 description 3
- 230000003467 diminishing effect Effects 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 230000004217 heart function Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 229940010747 sodium hyaluronate Drugs 0.000 description 3
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- 239000000275 Adrenocorticotropic Hormone Substances 0.000 description 2
- 101800001982 Cholecystokinin Proteins 0.000 description 2
- 102100025841 Cholecystokinin Human genes 0.000 description 2
- 102400000739 Corticotropin Human genes 0.000 description 2
- 101800000414 Corticotropin Proteins 0.000 description 2
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 2
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 2
- 229920002079 Ellagic acid Polymers 0.000 description 2
- 229920002527 Glycogen Polymers 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 2
- 230000006750 UV protection Effects 0.000 description 2
- 244000077233 Vaccinium uliginosum Species 0.000 description 2
- 206010047139 Vasoconstriction Diseases 0.000 description 2
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 2
- 241001135917 Vitellaria paradoxa Species 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 229930014669 anthocyanidin Natural products 0.000 description 2
- 150000001453 anthocyanidins Chemical class 0.000 description 2
- 235000008758 anthocyanidins Nutrition 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000000711 cancerogenic effect Effects 0.000 description 2
- 229960001631 carbomer Drugs 0.000 description 2
- 229940107137 cholecystokinin Drugs 0.000 description 2
- IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 description 2
- 229960000258 corticotropin Drugs 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 210000004207 dermis Anatomy 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229960002852 ellagic acid Drugs 0.000 description 2
- 235000004132 ellagic acid Nutrition 0.000 description 2
- 210000001339 epidermal cell Anatomy 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 235000020647 eyebright extract Nutrition 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000002191 fatty alcohols Chemical class 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 150000002212 flavone derivatives Chemical class 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 210000004211 gastric acid Anatomy 0.000 description 2
- 210000001156 gastric mucosa Anatomy 0.000 description 2
- 229940096919 glycogen Drugs 0.000 description 2
- 230000009931 harmful effect Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 239000003410 keratolytic agent Substances 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 230000001050 lubricating effect Effects 0.000 description 2
- 238000005461 lubrication Methods 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 229940057910 shea butter Drugs 0.000 description 2
- IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 239000000516 sunscreening agent Substances 0.000 description 2
- 239000002344 surface layer Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000008719 thickening Effects 0.000 description 2
- 230000009261 transgenic effect Effects 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- LODWEXDBRZBADB-XEVVZDEMSA-N (2s)-6-amino-2-[[(2s)-2-[[(2s)-6-amino-2-(hexadecanoylamino)hexanoyl]amino]-3-methylbutanoyl]amino]hexanoic acid Chemical compound CCCCCCCCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(O)=O LODWEXDBRZBADB-XEVVZDEMSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- DWHIUNMOTRUVPG-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCO DWHIUNMOTRUVPG-UHFFFAOYSA-N 0.000 description 1
- TYYHDKOVFSVWON-UHFFFAOYSA-N 2-butyl-2-methoxy-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(OC)(CCCC)C(=O)C1=CC=CC=C1 TYYHDKOVFSVWON-UHFFFAOYSA-N 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- KNFLNGRLKALWRF-LDXSYGEZSA-N CSCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(N)=O)CC1=CC=CC=C1 Chemical compound CSCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(N)=O)CC1=CC=CC=C1 KNFLNGRLKALWRF-LDXSYGEZSA-N 0.000 description 1
- 235000004032 Centella asiatica Nutrition 0.000 description 1
- 244000146462 Centella asiatica Species 0.000 description 1
- 240000003538 Chamaemelum nobile Species 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- 241000050051 Chelone glabra Species 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 230000033616 DNA repair Effects 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 101000761020 Dinoponera quadriceps Poneritoxin Proteins 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 241000221079 Euphorbia <genus> Species 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 206010019049 Hair texture abnormal Diseases 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- 229940124091 Keratolytic Drugs 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 241000530268 Lycaena heteronea Species 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- 101800001751 Melanocyte-stimulating hormone alpha Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 241000235395 Mucor Species 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 102000004270 Peptidyl-Dipeptidase A Human genes 0.000 description 1
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 244000153955 Reynoutria sachalinensis Species 0.000 description 1
- 235000003202 Reynoutria sachalinensis Nutrition 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- 241000235346 Schizosaccharomyces Species 0.000 description 1
- 241000221696 Sclerotinia sclerotiorum Species 0.000 description 1
- 208000028990 Skin injury Diseases 0.000 description 1
- 239000004902 Softening Agent Substances 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229930002945 all-trans-retinaldehyde Natural products 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229940051879 analgesics and antipyretics salicylic acid and derivative Drugs 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003260 anti-sepsis Effects 0.000 description 1
- 239000000043 antiallergic agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 208000003464 asthenopia Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 229960005193 avobenzone Drugs 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229940114081 cinnamate Drugs 0.000 description 1
- 229940080421 coco glucoside Drugs 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 210000003792 cranial nerve Anatomy 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000002740 effect on eyes Effects 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229940093476 ethylene glycol Drugs 0.000 description 1
- 238000005562 fading Methods 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000003752 improving hair Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000001361 intraarterial administration Methods 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 230000001530 keratinolytic effect Effects 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940031674 laureth-7 Drugs 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- UMFJAHHVKNCGLG-UHFFFAOYSA-N n-Nitrosodimethylamine Chemical compound CN(C)N=O UMFJAHHVKNCGLG-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000004297 night vision Effects 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 description 1
- 238000006384 oligomerization reaction Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 229940094912 palmitoyl tripeptide-5 Drugs 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000003169 placental effect Effects 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 229960004063 propylene glycol Drugs 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 239000011604 retinal Substances 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- NCYCYZXNIZJOKI-OVSJKPMPSA-N retinal group Chemical group C\C(=C/C=O)\C=C\C=C(\C=C\C1=C(CCCC1(C)C)C)/C NCYCYZXNIZJOKI-OVSJKPMPSA-N 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 231100000202 sensitizing Toxicity 0.000 description 1
- 230000001235 sensitizing effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 150000004756 silanes Chemical class 0.000 description 1
- 229910021332 silicide Inorganic materials 0.000 description 1
- FVBUAEGBCNSCDD-UHFFFAOYSA-N silicide(4-) Chemical compound [Si-4] FVBUAEGBCNSCDD-UHFFFAOYSA-N 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000003998 snake venom Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 231100000378 teratogenic Toxicity 0.000 description 1
- 230000003390 teratogenic effect Effects 0.000 description 1
- 208000023409 throat pain Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 1
- 230000025033 vasoconstriction Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- WHNFPRLDDSXQCL-UHFFFAOYSA-N α-melanotropin Chemical compound C=1N=CNC=1CC(C(=O)NC(CC=1C=CC=CC=1)C(=O)NC(CCCNC(N)=N)C(=O)NC(CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)NC(CCCCN)C(=O)N1C(CCC1)C(=O)NC(C(C)C)C(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(CCSC)NC(=O)C(CO)NC(=O)C(NC(=O)C(CO)NC(C)=O)CC1=CC=C(O)C=C1 WHNFPRLDDSXQCL-UHFFFAOYSA-N 0.000 description 1
- WHNFPRLDDSXQCL-UAZQEYIDSA-N α-msh Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(N)=O)NC(=O)[C@H](CO)NC(C)=O)C1=CC=C(O)C=C1 WHNFPRLDDSXQCL-UAZQEYIDSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/732—Starch; Amylose; Amylopectin; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/92—Oral administration
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Dermatology (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Emergency Medicine (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a preparation method of pholiota nameko mucilage, and a skin care product and a beauty food prepared from the pholiota nameko mucilage, and the preparation method of the pholiota nameko mucilage comprises the steps of cleaning raw pholiota nameko, processing at the temperature of 105-121 ℃ for 25-40 minutes under the pressure of 0.15-0.35MPa, and filtering to obtain the pholiota nameko mucilage; a skin care product prepared by using nameko mushroom mucilage specifically comprises the application of preparing essence, a facial mask, toner, cream, eye cream and the like; a skin caring food prepared from Pholiota nameko mucilage specifically comprises application in preparing oral liquid. The pholiota nameko mucilage prepared by the method can be directly added into cosmetics and food, and preservatives can also be added to be used as raw materials for storage and standby application, so that the safety and the reliability are realized, and the raw materials of the pholiota nameko are fully utilized.
Description
Technical Field
The invention relates to the field of medicine preparation and application, in particular to a preparation method of pholiota nameko mucilage and a skin care product and a beauty food prepared from the pholiota nameko mucilage.
Background
Pholiota nameko (Pholiota nameko) also known as pearl mushroom, Pholiota nameko and Pholiota nameko is named because of the abundant mucus on the surface. The pholiota nameko mucilage contains nucleic acid, protein, 17 amino acids, pholiota nameko polysaccharide and other components, and the pholiota nameko polysaccharide and the nucleic acid are main active ingredients of the pholiota nameko mucilage. Wherein the polysaccharide has biological activities of resisting oxidation, clearing free radicals and the like, and the pholiota nameko polysaccharide has the capacity of eliminating DPPH free radicals which is close to Vc and reaches 41.28 percent at high-quality concentration (800 mu g/mL); pholiota nameko polysaccharide pair Fe2+The induced lipid peroxidation has a certain inhibition effect, and the inhibition effect is gradually enhanced along with the increase of the concentration. The natural nucleic acid has certain stimulation effect on frontal keratinized cells of human body, can regenerate and renew cells, absorb ultraviolet rays, prevent long spots, has the characteristics of ultraviolet resistance, aging resistance, moisture retention and the like, and has better sticky feeling and lubricating feeling.
The pholiota nameko raw material adopted in the current market is dehydrated dry pholiota nameko, and the pholiota nameko raw material is prepared by extraction and processing, so that a large amount of nutrient components are lost, the application effect is limited, and pholiota nameko mucilage is directly discarded, so that the resource waste is caused.
With the continuous development of daily chemical technology, natural cosmetics are favored due to the characteristics of high efficiency, safety, no stimulation and the like, and the market demand is increasing day by day. The natural nucleic acid contained in the pholiota nameko mucilage has the characteristics of ultraviolet resistance, aging resistance, moisture retention and the like, has better sticky feeling and lubricating feeling, and can reduce or replace a thickening agent, a lubricating agent and a moisturizing agent when being added into cosmetics. Cosmetic thickeners on the market such as xanthan gum, carbomer, silicified polymer, high molecular hyaluronic acid, acrylic acid (ester) and the like, cosmetic lubricants such as silicone oil, glycerin, silicide polymer and the like, cosmetic moisturizing agents such as alcohols, low molecular hyaluronic acid, silanes and the like, and the raw materials often have allergic reaction after being used by people; the pholiota nameko mucilage is natural in components, chemical treatment is not needed in the preparation process, so that the pholiota nameko mucilage is higher in safety, and the pholiota nameko mucilage is more remarkable in beautifying effect after being compounded with other biological raw materials.
The pholiota nameko oral liquid produced by utilizing pholiota nameko mucilage is not available in the market, food-grade thickening agents are added into most of other existing beautifying oral liquids, and the pholiota nameko mucilage has viscosity, so that the thickening agents do not need to be additionally added. In addition, aiming at people who are easy to get inflamed and allergic, the invention avoids using collagen, thickening agent, spice, sugar, thermal Chinese herbal medicine and plant components which are easy to get inflamed, and all adopts natural raw materials which are not easy to get inflamed and are not allergic.
Therefore, the need exists for a safe and efficient pholiota nameko mucilage, and further development of application of the pholiota nameko mucilage is needed. In order to solve the problems, the functional components of the pholiota nameko mucilage need to be further defined, the safety and the effectiveness of the pholiota nameko mucilage are verified, and the application field of the pholiota nameko mucilage is widened.
Disclosure of Invention
Aiming at the problems, the invention researches and designs a preparation method of pholiota nameko mucilage and a skin care product and a beauty food prepared from the pholiota nameko mucilage so as to solve the problems of resource waste caused by large loss of nutrient components and insufficient application of the pholiota nameko mucilage in the traditional pholiota nameko raw material extraction process. The technical means adopted by the invention are as follows:
a preparation method of pholiota nameko mucilage comprises the following steps: cleaning raw pholiota nameko, treating at the temperature of 105-.
Preferably, the treatment temperature is 121 ℃, the treatment time is 30 minutes, and the treatment pressure is 0.35 MPa.
A skin care product prepared from the pholiota nameko mucilage comprises the following components in parts by weight: 50-100 parts of distilled water, 3-10 parts of pholiota nameko mucilage, 0.25-0.5 part of soybean oligopeptide, 2-6 parts of polypeptide compound source liquid, 2-4 parts of natural amino acid humectant, 0.3-0.5 part of polyhydric alcohol, 0.5-2 parts of tree peony bark extract, 3-10 parts of tremella polysaccharide extract, 1-3 parts of cherry extract, 2-3 parts of centella extract, 1-2 parts of plant compound anti-allergic factor, 0.15-0.8 part of sclerotium rolfsii gum, 2-10 parts of hydrogenated starch hydrolysate and 0.5-1 part of PE 9010.
Preferably, the skin care product is essence and comprises the following components in parts by weight: 60-70 parts of distilled water, 3-8 parts of nameko mushroom mucus, 0.25-0.35 part of soybean oligopeptide, 3-5 parts of polypeptide compound source liquid, 3-4 parts of natural amino acid humectant, 0.3-0.4 part of polyhydric alcohol, 0.5-1 part of moutan bark extract, 5-8 parts of tremella polysaccharide extract, 1-2 parts of cherry extract, 2-3 parts of centella asiatica extract, 5-15 parts of rose extract, 1-2 parts of plant compound anti-allergic factor, 0.5-0.7 part of sclerotium rolfsii gum, 0.05-0.1 part of acrylate/C10-30 alkanol acrylate cross-linked polymer, 5-8 parts of yeast lysate 908 parts, 2-5 parts of hydrogenated starch hydrolysate, 2-3 parts of pomegranate extract, 0.02-0.04 part of 4-hydroxyethyl piperazine ethanesulfonic acid and 0.5-0.8 part of PE 10.
Preferably, the skin care product is a mask which comprises the following components in parts by weight: 70-80 parts of distilled water, 3-8 parts of nameko mushroom mucus, 0.25-0.35 part of soybean oligopeptide, 2-3 parts of polypeptide compound source liquid, 2-4 parts of natural amino acid humectant, 0.3-0.4 part of polyhydric alcohol, 0.5-1 part of moutan bark extract, 5-8 parts of tremella polysaccharide extract, 1-2 parts of cherry extract, 2-3 parts of centella asiatica extract, 10-15 parts of rose extract, 1-2 parts of plant compound anti-allergic factor, 0.3-0.5 part of sclerotium rolfsii gum, 0.05-0.1 part of acrylate/C10-30 alkanol acrylate cross-linked polymer, 2-5 parts of yeast lysate 909010 parts, 2-4 parts of hydrogenated starch hydrolysate, 1-2 parts of pomegranate extract, 0.01-0.02 part of 4-hydroxyethyl piperazine ethanesulfonic acid and 0.5-0.8 part of PE 10.
Preferably, the skin care product is toner which comprises the following components in parts by weight: 80-90 parts of distilled water, 3-5 parts of pholiota nameko mucilage, 0.3-0.5 part of soybean oligopeptide, 2-3 parts of polypeptide compound source liquid, 2-3 parts of natural amino acid humectant, 0.3-0.4 part of polyhydric alcohol, 0.5-1 part of moutan bark extract, 3-5 parts of tremella polysaccharide extract, 1-2 parts of cherry extract, 2-3 parts of centella extract, 10-15 parts of rose extract, 1-2 parts of plant compound anti-allergic factor, 0.15-0.25 part of sclerotium rolfsii gum, 2-3 parts of hydrogenated starch hydrolysate and 0.5-0.8 part of PE 9010.
Preferably, the skin care product is a face cream which comprises the following components in parts by weight: 60-70 parts of distilled water, 3-5 parts of nameko mushroom mucus, 0.25-0.3 part of soybean oligopeptide, 3-4 parts of polypeptide compound source liquid, 2-4 parts of natural amino acid humectant, 0.3-0.4 part of polyhydric alcohol, 0.5-1 part of moutan bark extract, 3-5 parts of tremella polysaccharide extract, 1-2 parts of cherry extract, 2-3 parts of centella extract, 1-2 parts of plant compound anti-allergic factor, 0.6-0.7 part of sclerotium rolfsii gum, 0.05-0.15 part of acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer, 2-5 parts of hydrogenated starch hydrolysate, 1-3 parts of pomegranate extract, 0.05-0.1 part of pearl powder, 3-5 parts of emulsifier, 10-15 parts of vegetable oil, 2-5 parts of organosilicon 9010 and 0.5-0.8 part of PE 9010.
Preferably, the skin care product is eye cream which comprises the following components in parts by weight: 50-60 parts of distilled water, 3-5 parts of nameko mushroom mucus, 0.25-0.3 part of soybean oligopeptide, 3-4 parts of polypeptide compound source liquid, 2-4 parts of natural amino acid humectant, 0.3-0.4 part of polyhydric alcohol, 0.5-1 part of tree peony bark extract, 3-5 parts of tremella polysaccharide extract, 1-2 parts of cherry extract, 2-3 parts of asiatic centella extract, 1-2 parts of plant composite anti-allergic factor, 0.6-0.7 part of sclerotium rolfsii gum, 0.05-0.1 part of acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer, 2-5 parts of hydrogenated starch hydrolysate, 1-2 parts of pomegranate extract, 3-5 parts of emulsifier, 5-10 parts of vegetable oil, 990510-15 parts of organic silicon, 1-3 parts of safflower extract and 2-5 parts of millet extract, 2-4 parts of elderberry extract and 0.5-0.8 part of PE 9010.
A beauty food prepared by applying the pholiota nameko mucilage comprises the following components in parts by weight: 50-70 parts of purified water, 5-10 parts of pholiota nameko mucilage, 5-10 parts of soybean oligopeptide, 5-10 parts of sea buckthorn stock solution, 5-10 parts of honey and 5-10 parts of blueberry concentrated solution.
Preferably, the beauty food is oral liquid which comprises the following components in parts by weight: 50-70 parts of purified water, 5-10 parts of pholiota nameko mucilage, 5-10 parts of soybean oligopeptide, 5-10 parts of sea buckthorn stock solution, 5-10 parts of honey and 5-10 parts of blueberry concentrated solution.
Compared with the prior art, the preparation method of the pholiota nameko mucilage and the skin care product and the beauty food prepared from the pholiota nameko mucilage have the following beneficial effects:
1. the pholiota nameko mucilage prepared by the method can be directly added into cosmetics and food, and preservatives can also be added to be used as raw materials for storage and standby application, so that the safety and the reliability are realized, and the raw materials of the pholiota nameko are fully utilized.
2. The pholiota nameko mucilage prepared by the method is used as an ideal thickening agent, lubricant or humectant, so that the viscosity and the softness of the product can be effectively improved; it has no toxicity to melanocyte, epidermal cell and dermal cell; non-sensitizing, carcinogenic, teratogenic; the stability is good.
3. The pholiota nameko mucilage is applied to beauty care products, such as essence, emulsion, toner, mask, cream and the like, and can resist oxidation, whiten skin, remove color spots, remove wrinkles, repair, preserve moisture, enhance skin smoothness and improve skin sensitivity; compared with the existing beauty products, the pholiota nameko mucilage disclosed by the invention has a better effect and higher safety.
4. The pholiota nameko mucilage is prepared into beauty and health care food in the forms of oral liquid, beverage and the like, and can improve the immunity and the oxidation resistance of a human body, promote metabolism, clear free radicals in the body and prevent diseases.
Detailed Description
Example 1:
a preparation method of pholiota nameko mucilage comprises the following steps: cleaning fresh pholiota nameko cultured in a dust-free room, removing attachments on the surface layer, putting into a sealed tank made of a high-temperature resistant material, sealing, sending into an autoclave, setting the pressure to be 0.35MPa, the temperature to be 121 ℃, sterilizing for 30 minutes, fusing the water in the pholiota nameko subjected to high-pressure high-temperature sterilization with surface-layer nucleic acid polysaccharide amino acid to generate mucus, and filtering the obtained pholiota nameko raw material to obtain the pholiota nameko mucus. The pholiota nameko mucilage subjected to high-temperature and high-pressure treatment can be filtered to obtain 450ml per 1kg on average.
Example 2:
when the pholiota nameko mucilage is used as a softening agent, a moisturizing agent or a thickening agent to prepare a skin care product, the effects of inhibiting the generation of melanin, removing skin pigment deposition and pigmented spots, repairing acne, promoting the renewal of aged skin, enhancing the smoothness of the skin, improving the skin sensitivity, increasing the moisture content of the skin, enhancing the skin elasticity, resisting wrinkles and resisting aging are achieved.
Comparative example 1:
the effect of the pholiota nameko mucilage and a common thickener are evaluated and compared.
When the pholiota nameko mucilage is used as a skin care product thickener in an amount of 10-30%, no anaphylactic reaction occurs in 30 sensitive people; conventional thickeners such as sodium hyaluronate, sodium alginate, hydroxycellulose, xanthan gum, locust bean gum, and carbomer are added according to the minimum recommended addition level, and all people have allergy.
Therefore, the pholiota nameko mucilage is superior to other thickening agents in the aspect of safety as a skin care product thickening lubricant.
Comparative example 2:
and evaluating and comparing the action effects of the pholiota nameko mucilage and the common emollient.
The sclerotium rolfsii and the pholiota nameko mucilage are safe plant-derived emollients, humectants and thickeners, and cannot cause allergy even if the addition amount is large. When the essence and the facial mask are prepared, the skin feel is sticky when the addition amount of the sclerotium rolfsii powder reaches more than 0.7 percent; if the addition amount is less than 0.5%, the liquid fluidity is too large, and the lubrication degree is not enough; after 5% -15% of pholiota nameko mucilage is added, the skin feel of the product is the same as that of the product added with 1% -2% of silicone oil, but the silicone oil belongs to chemicals, is not easy to absorb and is easy to cause acne.
Comparative example 3:
and evaluating and comparing the action effect of the pholiota nameko mucilage and a common humectant.
The comparison of pholiota nameko mucilage and humectants such as butanediol, sodium hyaluronate, etc. was evaluated.
5-15% of pholiota nameko mucilage is added to prepare a mask, after the mask is applied to the face for 20 minutes, no anaphylactic reaction occurs in the test of 10 sensitive people, and the dry skin is obviously improved; after other moisturizers such as butanediol or sodium hyaluronate are added into the facial mask according to the minimum standard of the recommended addition amount, people have different degrees of allergy within 10 minutes to 24 hours.
Therefore, the pholiota nameko mucilage is superior to other moisturizing agents in the aspect of safety as a skin care product moisturizing agent.
According to comparative examples 2 and 3, the pholiota nameko mucilage can increase the lubrication degree, is safer than silicone oil, can reduce the addition amount of sclerotium rolfsii gum, and is a very safe plant-derived emollient, humectant or thickener as the sclerotium rolfsii gum. Therefore, a part of the pholiota nameko mucilage and the sclerotium rolfsii gum can be selected to be compounded into an emollient, a humectant or a thickening agent to be added into the skin care product for use.
Example 3:
a skin care product prepared by using pholiota nameko mucilage comprises the following components in parts by weight: 50-100 parts of distilled water, 3-10 parts of nameko mushroom mucus, 0.25-0.5 part of soybean oligopeptide, 2-6 parts of polypeptide compound source liquid, 2-4 parts of natural amino acid humectant, 0.3-0.5 part of polyhydric alcohol, 0.5-2 parts of tree peony bark extract, 3-10 parts of tremella polysaccharide extract, 1-3 parts of cherry extract, 2-3 parts of asiatic centella extract, 5-15 parts of rose extract, 1-3 parts of safflower extract, 2-5 parts of common euphorbia herb extract, 2-4 parts of elderberry extract, 1-2 parts of plant compound anti-allergic factor, 0.15-0.8 part of sclerotium rolfsii gum, 0.05-0.3 part of acrylic acid (ester)/C10-30 acrylate alkanol cross-linked polymer, 2-8 parts of schizosaccharomyces cerevisiae lysate fermentation product, 2-10 parts of hydrogenated starch hydrolysate, 1-5 parts of pomegranate extract, 0.5-5 parts of emulsifier, 0.01-0.04 part of 4-hydroxyethyl piperazine ethanesulfonic acid, 5-15 parts of vegetable oil, 0.05-0.1 part of pearl powder, 2-15 parts of organic silicon 9905 and 0.5-1 part of PE 9010.
The amount of the above components can be selected by those skilled in the art according to the needs, so as to prepare different specific application forms of toner, essence, emulsion, facial mask, cream, shampoo, hair conditioner and the like. It will be appreciated that, in addition to the ingredients particularly mentioned above, the formulations of the invention may include excipients or carriers conventional in the art having regard to the type of formulation in question. In addition to the preservatives described above, other preservatives or non-preservative substitutes may also be used.
Among the raw materials, the soybean oligopeptide is a non-transgenic soybean zymolyte with the average molecular weight of 500-1500, has small molecular weight, is easy to be absorbed by skin, and has the functions of replenishing water, resisting oxidation and enhancing skin immunity.
The polypeptide compound source liquid is water solution prepared from seven amino acids with different sequences, specifically 0.001% nonapeptide-1, 0.001% tripeptide-1 (GHK), 0.001% palmitoyl tripeptide-5, 0.0002% oligopeptide, 0.0002% snake venom peptide, 2% blue copper peptide and 0.002% hexapeptide, and the seven amino acids respectively have the effects of resisting wrinkles, whitening skin, promoting the growth of subcutaneous collagen and repairing skin injury.
The natural amino acid humectant is proline, and is effective component extracted from fructus Lycii and herba Zosterae Marinae.
The polyalcohol is a compound of caprylyl hydroximic acid, butanediol and 1, 2 hexanediol, and has antibacterial and antiseptic effects.
The moutan bark extract, the tremella polysaccharide extract, the cherry extract, the centella asiatica extract, the rose extract, the safflower extract, the eyebright extract and the elderberry extract are all effective substances obtained by water extraction. Wherein, the moutan bark extract has the functions of antibiosis and antisepsis; the tremella polysaccharide is rich in natural plant colloid, can moisten skin in cosmetic application, and has the effects of removing chloasma and freckle on the face; the vitamin C in the cherry extract can promote skin collagen proliferation, the skin can keep moisture and elasticity by being supplemented with moisturizing ingredients such as amino acid proline, sclerotium rolfsii gum and the like, and the cherry contains a tartaric acid ingredient, so that dead skin can be removed, pores can be effectively compacted, the surface of the skin is smooth, and the texture of the skin is more delicate; the herba Centellae extractive solution has effects of diminishing inflammation and calming, stimulating deep skin cell replacement, tightening the connection part of epidermis and dermis, promoting collagen formation in dermis, regenerating fibrin, and promoting the healing of damaged tissue; the rose extract has the functions of supplementing water, moisturizing and promoting capillary vasoconstriction; the safflower extract, the eyebright extract and the elderberry extract can improve eye blood circulation and relieve dark circles.
The plant composite anti-allergic factor is a 30% aqueous solution obtained by extracting centella asiatica, giant knotweed rhizome, baical skullcap root, tea extract, glabrous licorice root, chamomile and rosemary with water, and has the effects of relieving allergy, diminishing inflammation, resisting oxidation, resisting aging, preserving moisture and whitening as a multi-herb anti-allergic agent.
Sclerotium rolfsii gum is a water-soluble biopolymer produced by fermentation using mushroom as a substrate. The sclerotium rolfsii gum is a low-risk component which is considered to be safe by a cosmetic database at 99%, has good applicability in a wide pH value range, has great tolerance to various electrolytes in a solution, has high pseudoplasticity, and has little change of the viscosity of the solution along with the rise and fall of the temperature. Meanwhile, the skin care product has the effects of diminishing inflammation, preserving moisture, repairing and removing free radicals and has the natural effect of relieving the skin. Sclerotinia sclerotiorum gum can help to stabilize the emulsion and control viscosity according to the cosmetic database [2 ]. It can be used in cosmetics for preventing pigment separation, and has effects of softening, moistening, thickening, and scavenging free radicals by compounding with mucor of nameko with biological activities of resisting oxidation, resisting tumor, resisting aging, and enhancing immunity.
The lysate of the yeast fermentation product of the bifidus is a complex of metabolite, cytoplasmic fragments, cell wall components and polysaccharide obtained after the culture, inactivation and decomposition of bifidobacterium. The lysate of the yeast fermentation product of the bifidus can help epidermal cells and dermal cells to resist the harmful effect of UVB rays, promote DNA repair, generate small molecules such as vitamin B groups, minerals and amino acids which are beneficial to skin care, strengthen the metabolism of cuticle, capture free radicals, inhibit the peroxidation of lipid and have the functions of whitening and resisting aging.
The hydrogenated starch hydrolysate is formed by fermenting plants, is a mixture with viscous, colorless and cool feeling, mainly contains maltooligosaccharide glucoside/hydrogenated starch hydrolysate, has no stimulation to skin, protects the skin from external damage, has long moisturizing time, promotes cell growth, prevents cell drying, protects cells, avoids ultraviolet ray from damaging the cells, has an anti-inflammatory effect, improves the rough skin effect, inhibits the generation of anaerobic bacteria (acne bacteria), and can improve the fineness of foam of the product in a washing product to ensure that the foam lasts longer. And can improve hair dryness and wet combing property, repair damaged hair, and protect hair.
The pomegranate extract is a newly discovered skin-beautifying sanctus, contains anthocyanin and polyphenol, has quite excellent antioxidant effect, wherein anthocyanidin (ellagic acid) has the effect of resisting inflammation, and is a whitening component published by health agencies, so that the pomegranate extract stock solution can be used for skin care, can strengthen skin cells to resist free radicals, and can be used for caring skin even for allergic skin.
4-hydroxyethyl piperazine ethanesulfonic acid can very mildly promote the old keratinocyte peeling of the skin epidermal layer. Can smooth and soften skin, brighten skin color and achieve the effect of whitening.
The vegetable oil is refined pure Shea butter from Africa, and has effects of no allergy, moistening and keeping moisture.
According to different types of skin care products prepared from the raw materials, 20 volunteers aged 30-45 years are tested, and no anaphylactic reaction occurs after feedback. After 2 months of use, the canthus wrinkles are obviously improved by the feedback of a 32-year-old user. Through feedback of a 37-year-old acne patient, the inflammation is improved by 30% after 1 day of use, the acne starts to scab and fall off after 2-3 days of use, and the acne mark disappears by 40% after 1 week of use. After one allergy patient tests feedback, after the skin care product is used for 2 days, the allergy symptoms are obviously improved, new skin grows out, and the damaged skin gradually falls off.
Example 4:
the skin care product prepared by using the pholiota nameko mucilage as an active ingredient of the present invention may further contain adjuvants commonly used in beauty care and skin care, such as hydrophilic or lipophilic gelling agents, hydrophilic or lipophilic active agents, preservatives, antioxidants, solvents, perfumes, sunscreens, pigments, fragrance absorbents and colorants. The amount of each adjuvant can be selected by one skilled in the art as desired.
Active agents that may be used in conjunction with the pholiota nameko mucilage of the present invention include, but are not limited to, ellagic acid and derivatives thereof, hydroquinone, arbutin, resorcinol and derivatives thereof, vitamin C and derivatives thereof, pantothenic acid sulfonate and derivatives thereof, kojic acid, placental extract, molecules that directly or indirectly interfere with α -melanotropin (α -MSH) or its receptors or adrenocorticotropic hormone (ACTH), polyols such as glycerol, ethylene glycol or propylene glycol, vitamins, keratolytic or desquamating agents such as salicylic acid and derivatives thereof, α -hydroxyacids such as lactic acid or malic acid, ascorbic acid and derivatives thereof, retinoic acid, retinal, retinol and derivatives thereof, anti-inflammatory agents, emollients and mixtures thereof, chemical or physical sun screening agents such as zinc oxide micronized, titanium oxide, butyl methoxydibenzoylmethane and methoxyoctyl cinnamate, and deoxyribonucleic acid and nucleic acids.
An emulsion prepared by using the pholiota nameko mucilage comprises common raw material substances in the field, such as pholiota nameko mucilage, oil, an emulsifier, a co-emulsifier and the like, wherein the weight percentage of a lipid phase can be 5-80%, and is preferably 5-50%; the proportion by weight of emulsifier and co-emulsifier may be from 0.3 to 30%, preferably from 0.5 to 10%.
Of the above materials, oils include mineral oils, oils of vegetable origin (such as jojoba oil, shea butter), oils of animal origin (such as lanolin) or synthetic oils (such as perhydrosqualene), and in addition, fatty alcohols, fatty acids and waxes can be used as the fatty substance.
Emulsifiers and co-emulsifiers include glycoside emulsifiers of vegetable origin (e.g., stearyl alcohol and coco glucoside), fatty alcohol polyethers (e.g., laureth-7), sodium polyacrylates (e.g., sodium polyacrylate c 18-21-alkyltrideceth-6), and fatty acid esters of glycerol (e.g., glyceryl stearate).
Example 5:
a beauty food prepared by using pholiota nameko mucilage comprises but is not limited to oral liquid, syrup, dairy products and beverage forms, and the beauty food comprises the following components in parts by weight: 50-70 parts of purified water, 5-10 parts of nameko mushroom mucus, 5-10 parts of soybean oligopeptide, 5-10 parts of sea-buckthorn stock solution, 5-10 parts of honey, 5-10 parts of blueberry concentrated solution and potassium sorbate (according to the national standard).
Furthermore, as the pholiota nameko mucilage is prepared by specially selecting the pholiota nameko fresh mushrooms as the raw material, the obtained mucilage can be directly taken, the dose is 30ML-60ML per day, and the bioavailability of the extract can be improved.
Further, the soybean oligopeptide is a non-transgenic soybean zymolyte with the average molecular weight of 500-1500; the sea-buckthorn stock solution is pure sea-buckthorn juice without additives; the blueberry concentrated solution is organic wild blueberry without additives, and is prepared by 5-8 times of concentration and fermentation.
The preparation method of the oral liquid can select conventional antiseptic in the field, and can also use high temperature and high pressure sealed package without antiseptic.
In the raw materials, the pholiota nameko mucilage has the effects of promoting immunity, resisting aging and the like, and the pholiota nameko polysaccharide has biological activities of resisting oxidation, resisting tumors, resisting aging, enhancing immunity and the like.
The soybean oligopeptide has certain antioxidant capacity and can help human body resist free radicals, because histidine and tyrosine in the residue can eliminate the free radicals or chelate metal ions. Can inhibit the activity of angiotensin converting enzyme, thereby preventing peripheral vasoconstriction, and lowering blood pressure, without lowering blood pressure for normal blood pressure. The soybean oligopeptide can prolong exercise time, increase the content of muscle glycogen and liver glycogen, and reduce the content of lactic acid in blood, thereby relieving fatigue. The soybean oligopeptide can promote bile acidification, effectively discharge cholesterol, and prevent excessive absorption of cholesterol, thereby reducing blood lipid and blood cholesterol concentration. The soybean oligopeptide can reduce the content of cholesterol and triglyceride in vivo, stimulate the secretion of CCK (cholecystokinin), regulate the food intake of organism, and increase satiety. In addition, the soybean peptide also has the effects of regulating immunity, reducing blood sugar and the like. The molecular weight of soybean polypeptide is below 1000 on average, and the oligomerization reaches the level of being directly absorbed by human intestinal tract.
The fructus Hippophae stock solution has effects of promoting blood circulation and removing blood stasis. The total flavone contained in fructus Hippophae has effects of improving myocardial microcirculation, reducing oxygen consumption of myocardium, and can be used for treating angina pectoris, improving myocardial blood supply state, and enhancing heart function. The sea-buckthorn has the effects of promoting digestion, resolving stagnation, strengthening spleen and nourishing stomach, and the nutritional elements contained in the sea-buckthorn can effectively protect gastric mucosa and inhibit the secretion of gastric acid, so that the damage degree of the gastric mucosa is reduced, and the sea-buckthorn has good effects on dyspepsia, gastritis, chronic constipation and the like. The sea buckthorn contains abundant vitamins, wherein vitamin C, vitamin A, vitamin E and carotenoid are main skin care components, and VC has the effects of oxidation resistance, whitening and spot fading. The superoxide dismutase contained in fructus Hippophae has the functions of regulating immune system, regulating immune cells, improving disease resistance, and delaying aging. The sea-buckthorn is called the king of vitamin C, and a large amount of vitamin C can improve the oxygen content of brain cells of people and is beneficial to relieving fatigue. The sea-buckthorn contains rich amino acids, so that the sleep of people can be effectively improved, the memory can be improved, and the normal activity of the nervous system can be maintained. Sea buckthorn has the function of blocking and preventing the horrible carcinogen N-dimethyl nitrosamine. The flavone component contained in fructus Hippophae has anticancer effect.
The blueberry concentrated solution can enhance the resistance of human bodies to infectious diseases. Blueberry berries contain abundant high fiber and can be used as a good source of fiber in daily diet. Blueberry also contains abundant potassium, and can help to maintain the balance of body fluid, normal blood pressure and heart function. Anthocyanidin in blueberry fruit is a very strong antioxidant, and can help prevent the formation of intra-arterial plaque and various cancers and reduce the possibility of cancer. Research of USDA shows that the blueberry has the strongest antioxidant capacity in more than 40 fruits and vegetables which are frequently eaten by people, which means that more antioxidants capacity against aging, cancer and heart diseases can be realized by eating the blueberry. The blueberry is rich in vitamin C, has the effects of enhancing cardiac function, preventing cancer and heart disease, preventing cranial nerve aging and improving mental power, and also has certain improvement effect on common cold, throat pain and diarrhea. Researches show that the anthocyanin pigment has good health-care effect on eyes, can relieve eye fatigue and improve night vision, and the anthocyanin pigment rich in the blueberry fruit is particularly suitable for people with long-term work of eyes.
The skin caring health food prepared from the above materials has natural fruit taste, and does not need essence and sweetener harmful to human body. According to the condition that physiological functions of a human body after the age of 30 years are gradually declined, the immunity and the oxidation resistance of the human body are improved, metabolism is promoted, free radicals in the human body are cleared, and diseases are prevented, the raw materials are prepared into a beauty and health food containing pholiota nameko mucus, and 10 volunteers between the age of 30 and the age of 65 are tested.
The test result is fed back by 1 user of 37 years old, and the gastric acid regurgitation condition is improved after 1 month of use; after the feedback of a 60-year-old user, the sleep quality is improved after the use for 1 month; after the feedback of a 37-year-old user, the mental condition is improved after the use for 2 months; the feedback of 7 testers shows that the body resistance is improved after 1 month of use; there were 6 subjects who had feedback and improved the rough skin pigmentation after 2 months of use; none of the above subjects had symptoms of allergy and excessive internal heat.
The above-mentioned embodiments are merely illustrative of the preferred embodiments of the present invention, and do not limit the scope of the present invention, and various modifications and improvements of the technical solution of the present invention by those skilled in the art should fall within the protection scope defined by the claims of the present invention without departing from the spirit of the present invention.
Claims (10)
1. A preparation method of pholiota nameko mucilage is characterized by comprising the following steps: the method comprises the following steps: cleaning raw pholiota nameko, treating at the temperature of 105-.
2. The preparation method of pholiota nameko mucilage according to claim 1, wherein the preparation method comprises the following steps: the treatment temperature was 121 ℃, the treatment time was 30 minutes, and the treatment pressure was 0.35 MPa.
3. A skin care product prepared by applying the pholiota nameko mucilage of claim 1, wherein the skin care product comprises the following components in parts by weight: the paint comprises the following components in parts by weight: 50-100 parts of distilled water, 3-10 parts of pholiota nameko mucilage, 0.25-0.5 part of soybean oligopeptide, 2-6 parts of polypeptide compound source liquid, 2-4 parts of natural amino acid humectant, 0.3-0.5 part of polyhydric alcohol, 0.5-2 parts of tree peony bark extract, 3-10 parts of tremella polysaccharide extract, 1-3 parts of cherry extract, 2-3 parts of centella extract, 1-2 parts of plant compound anti-allergic factor, 0.15-0.8 part of sclerotium rolfsii gum, 2-10 parts of hydrogenated starch hydrolysate and 0.5-1 part of PE 9010.
4. The skin care product prepared by using the pholiota nameko mucilage of claim 1 according to claim 3, wherein the skin care product comprises: the skin care product is essence and comprises the following components in parts by weight: 60-70 parts of distilled water, 3-8 parts of nameko mushroom mucus, 0.25-0.35 part of soybean oligopeptide, 3-5 parts of polypeptide compound source liquid, 3-4 parts of natural amino acid humectant, 0.3-0.4 part of polyhydric alcohol, 0.5-1 part of moutan bark extract, 5-8 parts of tremella polysaccharide extract, 1-2 parts of cherry extract, 2-3 parts of centella asiatica extract, 5-15 parts of rose extract, 1-2 parts of plant compound anti-allergic factor, 0.5-0.7 part of sclerotium rolfsii gum, 0.05-0.1 part of acrylate/C10-30 alkanol acrylate cross-linked polymer, 5-8 parts of yeast lysate 908 parts, 2-5 parts of hydrogenated starch hydrolysate, 2-3 parts of pomegranate extract, 0.02-0.04 part of 4-hydroxyethyl piperazine ethanesulfonic acid and 0.5-0.8 part of PE 10.
5. The skin care product prepared by using the pholiota nameko mucilage of claim 1 according to claim 3, wherein the skin care product comprises: the skin care product is a facial mask which comprises the following components in parts by weight: 70-80 parts of distilled water, 3-8 parts of nameko mushroom mucus, 0.25-0.35 part of soybean oligopeptide, 2-3 parts of polypeptide compound source liquid, 2-4 parts of natural amino acid humectant, 0.3-0.4 part of polyhydric alcohol, 0.5-1 part of moutan bark extract, 5-8 parts of tremella polysaccharide extract, 1-2 parts of cherry extract, 2-3 parts of centella asiatica extract, 10-15 parts of rose extract, 1-2 parts of plant compound anti-allergic factor, 0.3-0.5 part of sclerotium rolfsii gum, 0.05-0.1 part of acrylate/C10-30 alkanol acrylate cross-linked polymer, 2-5 parts of yeast lysate 909010 parts, 2-4 parts of hydrogenated starch hydrolysate, 1-2 parts of pomegranate extract, 0.01-0.02 part of 4-hydroxyethyl piperazine ethanesulfonic acid and 0.5-0.8 part of PE 10.
6. The skin care product prepared by using the pholiota nameko mucilage of claim 1 according to claim 3, wherein the skin care product comprises: the skin care product is toner which comprises the following components in parts by weight: 80-90 parts of distilled water, 3-5 parts of pholiota nameko mucilage, 0.3-0.5 part of soybean oligopeptide, 2-3 parts of polypeptide compound source liquid, 2-3 parts of natural amino acid humectant, 0.3-0.4 part of polyhydric alcohol, 0.5-1 part of moutan bark extract, 3-5 parts of tremella polysaccharide extract, 1-2 parts of cherry extract, 2-3 parts of centella extract, 10-15 parts of rose extract, 1-2 parts of plant compound anti-allergic factor, 0.15-0.25 part of sclerotium rolfsii gum, 2-3 parts of hydrogenated starch hydrolysate and 0.5-0.8 part of PE 9010.
7. The skin care product prepared by using the pholiota nameko mucilage of claim 1 according to claim 3, wherein the skin care product comprises: the skin care product is a face cream which comprises the following components in parts by weight: 60-70 parts of distilled water, 3-5 parts of nameko mushroom mucus, 0.25-0.3 part of soybean oligopeptide, 3-4 parts of polypeptide compound source liquid, 2-4 parts of natural amino acid humectant, 0.3-0.4 part of polyhydric alcohol, 0.5-1 part of moutan bark extract, 3-5 parts of tremella polysaccharide extract, 1-2 parts of cherry extract, 2-3 parts of centella extract, 1-2 parts of plant compound anti-allergic factor, 0.6-0.7 part of sclerotium rolfsii gum, 0.05-0.15 part of acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer, 2-5 parts of hydrogenated starch hydrolysate, 1-3 parts of pomegranate extract, 0.05-0.1 part of pearl powder, 3-5 parts of emulsifier, 10-15 parts of vegetable oil, 2-5 parts of organosilicon 9010 and 0.5-0.8 part of PE 9010.
8. The skin care product prepared by using the pholiota nameko mucilage of claim 1 according to claim 3, wherein the skin care product comprises: the skin care product is eye cream which comprises the following components in parts by weight: 50-60 parts of distilled water, 3-5 parts of nameko mushroom mucus, 0.25-0.3 part of soybean oligopeptide, 3-4 parts of polypeptide compound source liquid, 2-4 parts of natural amino acid humectant, 0.3-0.4 part of polyhydric alcohol, 0.5-1 part of tree peony bark extract, 3-5 parts of tremella polysaccharide extract, 1-2 parts of cherry extract, 2-3 parts of asiatic centella extract, 1-2 parts of plant composite anti-allergic factor, 0.6-0.7 part of sclerotium rolfsii gum, 0.05-0.1 part of acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer, 2-5 parts of hydrogenated starch hydrolysate, 1-2 parts of pomegranate extract, 3-5 parts of emulsifier, 5-10 parts of vegetable oil, 990510-15 parts of organic silicon, 1-3 parts of safflower extract and 2-5 parts of millet extract, 2-4 parts of elderberry extract and 0.5-0.8 part of PE 9010.
9. A beauty food prepared by using the pholiota nameko mucilage of claim 1, wherein the beauty food comprises the following components: the paint comprises the following components in parts by weight: 50-70 parts of purified water, 5-10 parts of pholiota nameko mucilage, 5-10 parts of soybean oligopeptide, 5-10 parts of sea buckthorn stock solution, 5-10 parts of honey and 5-10 parts of blueberry concentrated solution.
10. The beauty food prepared by using the pholiota nameko mucilage of claim 1, according to claim 9, is characterized in that: the beauty food is oral liquid, which comprises the following components in parts by weight: 50-70 parts of purified water, 5-10 parts of pholiota nameko mucilage, 5-10 parts of soybean oligopeptide, 5-10 parts of sea buckthorn stock solution, 5-10 parts of honey and 5-10 parts of blueberry concentrated solution.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911419464.5A CN111000773A (en) | 2019-12-31 | 2019-12-31 | Preparation method of pholiota nameko mucilage and skin care product and beauty food prepared from pholiota nameko mucilage |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911419464.5A CN111000773A (en) | 2019-12-31 | 2019-12-31 | Preparation method of pholiota nameko mucilage and skin care product and beauty food prepared from pholiota nameko mucilage |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111000773A true CN111000773A (en) | 2020-04-14 |
Family
ID=70120053
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201911419464.5A Pending CN111000773A (en) | 2019-12-31 | 2019-12-31 | Preparation method of pholiota nameko mucilage and skin care product and beauty food prepared from pholiota nameko mucilage |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111000773A (en) |
Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS56151452A (en) * | 1980-04-25 | 1981-11-24 | Joji Watanabe | "pholiota nameko" preserved with "miso" and its preparation |
| JPH0723772A (en) * | 1993-07-12 | 1995-01-27 | Kureha Chem Ind Co Ltd | Heat-treated mycelium |
| RU2232571C1 (en) * | 2003-02-26 | 2004-07-20 | Институт биохимии и физиологии растений и микроорганизмов РАН | Biologically active additive for manufacturing cosmetic compositions |
| CN102793148A (en) * | 2011-05-23 | 2012-11-28 | 杨志强 | Method for processing instant nutrition pholiota nameko by utilizing ultrahigh pressure |
| CN104814921A (en) * | 2015-05-13 | 2015-08-05 | 朱敏 | Acne-removing scar-lightening mask solution, manufacturing method and acne-removing scar-lightening mask |
| CN105106102A (en) * | 2015-09-16 | 2015-12-02 | 福建绿宝食品集团有限公司 | Edible fungus lip balm and preparation method thereof |
| CN105687264A (en) * | 2014-11-28 | 2016-06-22 | 方端 | Hippophae rhamnoides linn fruit oral liquid for promoting growth and development and preparation method of hippophae rhamnoides linn fruit oral liquid |
| CN106805236A (en) * | 2017-01-20 | 2017-06-09 | 大连民族大学 | Extracting method and its application of mushroom mucus are slided with inoxidizability |
| CN108553346A (en) * | 2018-07-12 | 2018-09-21 | 哈尔滨伟平科技开发有限公司 | A kind of production method of anti-aging face cream |
| CN110179725A (en) * | 2018-04-04 | 2019-08-30 | 郭洪杰 | A kind of replenishing water and preserving moisture facial mask and preparation method thereof |
-
2019
- 2019-12-31 CN CN201911419464.5A patent/CN111000773A/en active Pending
Patent Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS56151452A (en) * | 1980-04-25 | 1981-11-24 | Joji Watanabe | "pholiota nameko" preserved with "miso" and its preparation |
| JPH0723772A (en) * | 1993-07-12 | 1995-01-27 | Kureha Chem Ind Co Ltd | Heat-treated mycelium |
| RU2232571C1 (en) * | 2003-02-26 | 2004-07-20 | Институт биохимии и физиологии растений и микроорганизмов РАН | Biologically active additive for manufacturing cosmetic compositions |
| CN102793148A (en) * | 2011-05-23 | 2012-11-28 | 杨志强 | Method for processing instant nutrition pholiota nameko by utilizing ultrahigh pressure |
| CN105687264A (en) * | 2014-11-28 | 2016-06-22 | 方端 | Hippophae rhamnoides linn fruit oral liquid for promoting growth and development and preparation method of hippophae rhamnoides linn fruit oral liquid |
| CN104814921A (en) * | 2015-05-13 | 2015-08-05 | 朱敏 | Acne-removing scar-lightening mask solution, manufacturing method and acne-removing scar-lightening mask |
| CN105106102A (en) * | 2015-09-16 | 2015-12-02 | 福建绿宝食品集团有限公司 | Edible fungus lip balm and preparation method thereof |
| CN106805236A (en) * | 2017-01-20 | 2017-06-09 | 大连民族大学 | Extracting method and its application of mushroom mucus are slided with inoxidizability |
| CN110179725A (en) * | 2018-04-04 | 2019-08-30 | 郭洪杰 | A kind of replenishing water and preserving moisture facial mask and preparation method thereof |
| CN108553346A (en) * | 2018-07-12 | 2018-09-21 | 哈尔滨伟平科技开发有限公司 | A kind of production method of anti-aging face cream |
Non-Patent Citations (1)
| Title |
|---|
| 黄小葳: ""多糖的非常规提取研究"", 《北京联合大学学报(自然科学版)》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5925348A (en) | Methods utilizing compositions containing sacred lotus (methyltransferase) to treat aging skin | |
| CN102293733B (en) | Overall whitening and speckle removal skin care product | |
| US6468564B1 (en) | Topical compositions containing lotus for skin treatment | |
| KR102265730B1 (en) | cosmetic composition for skin wrinkle improvement and whitening facial skin | |
| KR101810231B1 (en) | Cosmetic composition for improving acne containing propolis spicule powder | |
| KR101809266B1 (en) | Cosmetic composition containing propolis complex extracts | |
| KR102042960B1 (en) | Skin essence for skin moisturization and skin tone improvement | |
| JP2000191498A (en) | Collagen production facilitative agent and preparation for external use for skin | |
| CN113368018A (en) | Anti-inflammatory acne-removing composition and preparation method thereof | |
| CN106727033A (en) | A kind of anti-ageing lutein compound plant facial mask of moisturizing | |
| CN111450005A (en) | Beautifying and skin-brightening composition, beautifying and skin-brightening skin care product and preparation method thereof | |
| JP2010241762A (en) | Cosmetic | |
| CN111265441A (en) | Composition capable of enhancing skin night repair and regeneration capacity and application thereof | |
| CN111973501A (en) | Ceramide activation milk and preparation method thereof | |
| CN111973486A (en) | Ceramide moisturizing and moisture-keeping cream and preparation method thereof | |
| CN112137919B (en) | Application of dictyophora indusiata egg extract in preparation of external beauty and skin care products and external beauty and skin care products based on same | |
| KR20100006796A (en) | Anti-aging cosmetic composition comprising herb ferment extract | |
| KR101019094B1 (en) | Method for preparing cosmetic water for whitening | |
| JP3432175B2 (en) | Cell growth promotion cosmetics | |
| KR20170136919A (en) | Composition for improving skin condition comprising herb extracts mixture | |
| CN109481323A (en) | A kind of Aloe original juice moisturizing oil and preparation method thereof | |
| CN111700847B (en) | Composition for treating dark eye circles by synergistic laser, eye essence and preparation method | |
| KR20020016960A (en) | Skin Care Composition Containing Portulaca Extract | |
| CN111000773A (en) | Preparation method of pholiota nameko mucilage and skin care product and beauty food prepared from pholiota nameko mucilage | |
| CN109646359B (en) | Rose-agaric mud membrane paste with effects of cleaning, purifying, maintaining beauty and keeping young and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200414 |
|
| RJ01 | Rejection of invention patent application after publication |